Friday, 21 Jul 2017

You are here

EULAR 2017 – Day 1 Highlights

The Annual EULAR Congress kicked off this afternoon in Madrid with a number of new sessions devoted to:

  • Criteria revision in lupus, Sjogren's syndrome and the antiphospholipid syndrome
  • The cancer – autoimmunity balance and the lessons learned from checkpoint inhibitors and the development of Immune Related Adverse Events (IRAEs)
  • Wearable technologies
  • New EULAR campaign “Don’t Delay, Connect Today”.  (Promoting early diagnosis and the role of early interventions (including drug and lifestyle interventions)
  • Progress in Spondyloarthritis Management
  • Comorbidities and Rheumatic disease

Posters start tomorrow.

For many it was a day of meeting up with international colleagues and avoiding the 100 degree heat. (Burger King's air conditioning seems to be very appealing)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review – 21 July 2017

Dr. Jack Cush reviews the news from the past week on RheumNow.com: 

The RheumNow Week in Review – 14 July 2017

Dr. Jack Cush reviews highlights from the past week on RheumNow.com:

Pharma Pays $8.2 Billion to Physicians in 2016

Data made public by the Centers for Medicare & Medicaid Services shows that drug and device makers made nearly $8.2 billion in payments to U.S. physicians and teaching hospitals in the last year. Since 2013, CMS has been tracking physician payments as part of the Affordable Care Act.

The RheumNow Week in Review – 30 June 2017

Dr. Jack Cush reviews highlights from the past week on RheumNow.com:

ACR Says Senate Healthcare Bill Falls Short of Protecting Americans with Rheumatic Disease

Dr. Sharad Lakhanpal, President of the American College of Rheumatology has responded to the Senate's proposed changes to healthcare coverage in the USA.